155 related articles for article (PubMed ID: 32525563)
1. Cluster of differentiation 44 promotes osteosarcoma progression in mice lacking the tumor suppressor Merlin.
Ma J; Klemm J; Gerardo-Ramírez M; Frappart L; Castven D; Becker D; Zoch A; Parent R; Bartosch B; Minnich K; Giovannini M; Danckwardt S; Hartmann N; Morrison H; Herrlich P; Marquardt JU; Hartmann M
Int J Cancer; 2020 Nov; 147(9):2564-2577. PubMed ID: 32525563
[TBL] [Abstract][Full Text] [Related]
2. Deletion of
Gerardo-Ramírez M; Giam V; Becker D; Groth M; Hartmann N; Morrison H; May-Simera HL; Radsak MP; Marquardt JU; Galle PR; Herrlich P; Straub BK; Hartmann M
Cells; 2023 Apr; 12(9):. PubMed ID: 37174657
[TBL] [Abstract][Full Text] [Related]
3. Silencing of CD44 gene expression in human 143-B osteosarcoma cells promotes metastasis of intratibial tumors in SCID mice.
Gvozdenovic A; Arlt MJ; Campanile C; Brennecke P; Husmann K; Born W; Muff R; Fuchs B
PLoS One; 2013; 8(4):e60329. PubMed ID: 23565227
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin.
Bai Y; Liu YJ; Wang H; Xu Y; Stamenkovic I; Yu Q
Oncogene; 2007 Feb; 26(6):836-50. PubMed ID: 16953231
[TBL] [Abstract][Full Text] [Related]
5. Tumor Suppressor NF2 Blocks Cellular Migration by Inhibiting Ectodomain Cleavage of CD44.
Hartmann M; Parra LM; Ruschel A; Böhme S; Li Y; Morrison H; Herrlich A; Herrlich P
Mol Cancer Res; 2015 May; 13(5):879-90. PubMed ID: 25652588
[TBL] [Abstract][Full Text] [Related]
6. CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma.
Gerardo-Ramírez M; Keggenhoff FL; Giam V; Becker D; Groth M; Hartmann N; Straub BK; Morrison H; Galle PR; Marquardt JU; Herrlich P; Hartmann M
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955749
[TBL] [Abstract][Full Text] [Related]
7. Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.
Ahmad Z; Brown CM; Patel AK; Ryan AF; Ongkeko R; Doherty JK
Otol Neurotol; 2010 Apr; 31(3):460-6. PubMed ID: 20195187
[TBL] [Abstract][Full Text] [Related]
8. Absence of the CD44 gene prevents sarcoma metastasis.
Weber GF; Bronson RT; Ilagan J; Cantor H; Schmits R; Mak TW
Cancer Res; 2002 Apr; 62(8):2281-6. PubMed ID: 11956084
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells.
Alcantara KMM; Garcia RL
Oncol Rep; 2019 Apr; 41(4):2103-2116. PubMed ID: 30816526
[TBL] [Abstract][Full Text] [Related]
10. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
[TBL] [Abstract][Full Text] [Related]
11. NF2/Merlin suppresses proliferation and induces apoptosis in colorectal cancer cells.
Wu X; Mao F; Li N; Li W; Luo Y; Shi W; Ren J
Front Biosci (Landmark Ed); 2020 Jan; 25(3):513-525. PubMed ID: 31585900
[TBL] [Abstract][Full Text] [Related]
12. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.
Lallemand D; Curto M; Saotome I; Giovannini M; McClatchey AI
Genes Dev; 2003 May; 17(9):1090-100. PubMed ID: 12695331
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell MT1-MMP is dispensable for osteosarcoma tumor growth, bone degradation and lung metastasis.
Ingvarsen SZ; Gårdsvoll H; van Putten S; Nørregaard KS; Krigslund O; Meilstrup JA; Tran C; Jürgensen HJ; Melander MC; Nielsen CH; Kjaer A; Bugge TH; Engelholm LH; Behrendt N
Sci Rep; 2020 Nov; 10(1):19138. PubMed ID: 33154487
[TBL] [Abstract][Full Text] [Related]
14. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.
Poulikakos PI; Xiao GH; Gallagher R; Jablonski S; Jhanwar SC; Testa JR
Oncogene; 2006 Sep; 25(44):5960-8. PubMed ID: 16652148
[TBL] [Abstract][Full Text] [Related]
15. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression.
Xiao GH; Gallagher R; Shetler J; Skele K; Altomare DA; Pestell RG; Jhanwar S; Testa JR
Mol Cell Biol; 2005 Mar; 25(6):2384-94. PubMed ID: 15743831
[TBL] [Abstract][Full Text] [Related]
16. A splicing variant of Merlin promotes metastasis in hepatocellular carcinoma.
Luo ZL; Cheng SQ; Shi J; Zhang HL; Zhang CZ; Chen HY; Qiu BJ; Tang L; Hu CL; Wang HY; Li Z
Nat Commun; 2015 Oct; 6():8457. PubMed ID: 26443326
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells.
Liu T; Yan Z; Liu Y; Choy E; Hornicek FJ; Mankin H; Duan Z
Cell Physiol Biochem; 2018; 46(3):1218-1230. PubMed ID: 29672299
[TBL] [Abstract][Full Text] [Related]
18. Merlin deficiency alters the redox management program in breast cancer.
Mota M; Metge BJ; Hinshaw DC; Alsheikh HA; Chen D; Samant RS; Shevde LA
Mol Oncol; 2021 Apr; 15(4):942-956. PubMed ID: 33410252
[TBL] [Abstract][Full Text] [Related]
19. Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.
Chen Y; Gutmann DH; Haipek CA; Martinsen BJ; Bronner-Fraser M; Krull CE
Dev Dyn; 2004 Mar; 229(3):541-54. PubMed ID: 14991710
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.
Lee H; Kim D; Dan HC; Wu EL; Gritsko TM; Cao C; Nicosia SV; Golemis EA; Liu W; Coppola D; Brem SS; Testa JR; Cheng JQ
Mol Cell Biol; 2007 Mar; 27(6):2103-19. PubMed ID: 17210637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
